We are glad to announce that our application was accepted by the Novartis Foundation for Medical-Biological Research. This research project will be coordinated in collaboration with the Laboratory of Microsystems at EPFL headed by the Prof. Martin Gijs. We are looking forward to start this exciting project!
We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge SwitzerlandRead more about Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program[…]
In 2015, the project developed by Nagi Bioscience was the first recipient of the SGV 25th Fund. This fund was created by the SGV board to financially support projects related to the goals of the SGV, that are promotion of the Laboratory Animal Science and the Animal Welfare, and ethical considerations in animal experimentation. Read moreRead more about The platform developed by Nagi Bioscience is featured on the website of the Swiss Laboratory Animal Association (SGV)[…]
Gebert Rüf Stiftung fosters innovations for the benefit of Swiss economy and society, by supporting application-oriented and impact-oriented scientific projects at Swiss universities. The “Nematrix Project”, by Nagi Bioscience, became part of the GRS-supported project portfolio in November 2016.